Treatment of Patients With Active Neurocysticercosis in Eastern Africa

Inclusion Criteria

• •All patients will be included who
• •Meet the definitions of active NCC
• •Have epilepsy, epileptic seizures or chronic/severe progressive headaches
• •Are physically and mentally fit enough for treatment
• •Are willing to be hospitalized and to receive the standard treatment for NCC
• •Are willing to participate a follow-up for six months
• •Are willing and able to consent to this study, with consent recorded on a signed consent form
• •Women who are pregnant will not be included, but re-evaluated for inclusion into the study after they have given birth.
• •Potential participants who are currently taking or have taken albendazole, praziquantel, or a corticosteroid within the past 12 months will be excluded.
• •People with uncontrolled hypertension and/or diabetes will be excluded from the study but will be re-evaluated for inclusion once their hypertension and/or diabetes have been treated.
• •People with chronic consuming illness such as cancer and those with mental handicap severe enough to not allow them to follow the study instructions or reliably take their medication will be excluded.
• •Children aged \<10 years.